FR2825292B1 - Procede d'enrobage d'une substance active dans un complexe interpolymere - Google Patents

Procede d'enrobage d'une substance active dans un complexe interpolymere

Info

Publication number
FR2825292B1
FR2825292B1 FR0206670A FR0206670A FR2825292B1 FR 2825292 B1 FR2825292 B1 FR 2825292B1 FR 0206670 A FR0206670 A FR 0206670A FR 0206670 A FR0206670 A FR 0206670A FR 2825292 B1 FR2825292 B1 FR 2825292B1
Authority
FR
France
Prior art keywords
coating
active substance
complex
inter
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0206670A
Other languages
English (en)
Other versions
FR2825292A1 (fr
Inventor
Francis Sean Moolman
Heidi Rolfes
Der Merwe Thilo Lothar Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council for Scientific and Industrial Research CSIR
Original Assignee
Council for Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25589180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2825292(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Council for Scientific and Industrial Research CSIR filed Critical Council for Scientific and Industrial Research CSIR
Publication of FR2825292A1 publication Critical patent/FR2825292A1/fr
Application granted granted Critical
Publication of FR2825292B1 publication Critical patent/FR2825292B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicinal Preparation (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Paints Or Removers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FR0206670A 2001-05-30 2002-05-30 Procede d'enrobage d'une substance active dans un complexe interpolymere Expired - Lifetime FR2825292B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA200104451 2001-05-30

Publications (2)

Publication Number Publication Date
FR2825292A1 FR2825292A1 (fr) 2002-12-06
FR2825292B1 true FR2825292B1 (fr) 2006-06-09

Family

ID=25589180

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0206670A Expired - Lifetime FR2825292B1 (fr) 2001-05-30 2002-05-30 Procede d'enrobage d'une substance active dans un complexe interpolymere

Country Status (21)

Country Link
US (1) US7641917B2 (fr)
EP (1) EP1401404B1 (fr)
JP (1) JP4313196B2 (fr)
CN (1) CN1255099C (fr)
AT (1) ATE392203T1 (fr)
AU (1) AU2002310567B2 (fr)
BR (1) BR0210000A (fr)
CA (1) CA2455208C (fr)
CH (1) CH695418A5 (fr)
CY (1) CY1108199T1 (fr)
DE (2) DE60226140T2 (fr)
DK (1) DK1401404T3 (fr)
ES (1) ES2305250T3 (fr)
FR (1) FR2825292B1 (fr)
GB (1) GB2392619B (fr)
HK (1) HK1066488A1 (fr)
IT (1) ITMI20021169A1 (fr)
NL (1) NL1020706C2 (fr)
PT (1) PT1401404E (fr)
WO (1) WO2003013478A2 (fr)
ZA (1) ZA200309983B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392619B (en) 2001-05-30 2004-10-20 Csir Method of encapsulating an active substance
US7903319B2 (en) * 2006-07-11 2011-03-08 E Ink Corporation Electrophoretic medium and display with improved image stability
US20080082764A1 (en) * 2006-10-03 2008-04-03 Yi Feng Jang Memory accessing system and method
GB0812742D0 (en) * 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
GB201317756D0 (en) 2013-10-08 2013-11-20 Critical Pharmaceuticals Ltd New process
DE102018210030A1 (de) * 2018-06-20 2019-12-24 Thyssenkrupp Ag Verwendung und Recyclieren von überkritischen CO2 als Lösungsmittel für PLA und weitere biologisch abbaubaren Polymere in das Beschichtungsverfahren für Düngemittel
IT201800007993A1 (it) * 2018-08-09 2020-02-09 Greenbone Ortho Srl Impianto finalizzato alla trasformazione chimica di materiali nello stato 3d
CN112812355B (zh) * 2020-12-31 2022-09-23 厦门天生爱科技有限公司 一种具有缓释挥发性中草药有效成分的功能高分子发泡材料、制备方法和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500121D0 (en) 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells
ATE94782T1 (de) * 1987-12-21 1993-10-15 Union Carbide Corp Verwendung von superkritischen fluessigkeiten als verduenner beim aufspruehen von ueberzuegen.
EP0706821A1 (fr) * 1994-10-06 1996-04-17 Centre De Microencapsulation Procédé pour l'enrobage de particules
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
US6221399B1 (en) * 1995-08-17 2001-04-24 Csir Method of making controlled release particles of complexed polymers
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
AU735334B2 (en) * 1997-02-17 2001-07-05 Doppel Co., Ltd. Method for manufacturing artificial stone
GB9800936D0 (en) 1997-05-10 1998-03-11 Univ Nottingham Biofunctional polymers
ATE453460T1 (de) 1997-10-15 2010-01-15 Univ South Florida Beschichtung von partikelmaterial mittels superkritischer flüssigkeit
IT1296464B1 (it) * 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
GB9814619D0 (en) 1998-07-06 1998-09-02 Cole Polytechnique Fudurale De Materials and methods relating to encapsulation
US6340722B1 (en) 1998-09-04 2002-01-22 The University Of Akron Polymerization, compatibilized blending, and particle size control of powder coatings in a supercritical fluid
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
GB9920558D0 (en) 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
US6372259B1 (en) * 1999-11-10 2002-04-16 University Of Iowa Research Foundation Palatable, sustained release drug granules
WO2002020624A1 (fr) 2000-09-08 2002-03-14 Ferro Corporation Medicaments a liberation prolongee prepares par des techniques de traitement par fluides supercritiques
US6521258B1 (en) * 2000-09-08 2003-02-18 Ferro Corporation Polymer matrices prepared by supercritical fluid processing techniques
GB2392619B (en) 2001-05-30 2004-10-20 Csir Method of encapsulating an active substance

Also Published As

Publication number Publication date
EP1401404A2 (fr) 2004-03-31
DE60226140T2 (de) 2009-05-07
CH695418A5 (de) 2006-05-15
GB2392619B (en) 2004-10-20
EP1401404B1 (fr) 2008-04-16
DE10296849T5 (de) 2004-04-29
GB2392619A (en) 2004-03-10
AU2002310567B2 (en) 2005-10-20
ES2305250T3 (es) 2008-11-01
BR0210000A (pt) 2004-05-04
NL1020706A1 (nl) 2002-12-03
ITMI20021169A0 (it) 2002-05-30
ATE392203T1 (de) 2008-05-15
CA2455208C (fr) 2009-02-03
ZA200309983B (en) 2005-01-26
JP2005502642A (ja) 2005-01-27
WO2003013478A8 (fr) 2003-04-03
US20050112205A1 (en) 2005-05-26
HK1066488A1 (en) 2005-03-24
JP4313196B2 (ja) 2009-08-12
PT1401404E (pt) 2008-07-23
ITMI20021169A1 (it) 2003-12-01
CA2455208A1 (fr) 2003-02-20
DK1401404T3 (da) 2008-08-11
NL1020706C2 (nl) 2003-04-28
CN1512877A (zh) 2004-07-14
WO2003013478A3 (fr) 2003-05-30
US7641917B2 (en) 2010-01-05
GB0327381D0 (en) 2003-12-31
WO2003013478A2 (fr) 2003-02-20
DE60226140D1 (de) 2008-05-29
CY1108199T1 (el) 2014-02-12
FR2825292A1 (fr) 2002-12-06
CN1255099C (zh) 2006-05-10

Similar Documents

Publication Publication Date Title
EA200400483A1 (ru) Способ обработки порошков сжиженными газами
WO2003051286A3 (fr) Compositions, dispositifs et composants a base d'hydrogel
ES2138085T3 (es) Xinafoato de salmeterol con tamaño de particula controlado.
DE69525726D1 (de) Glatte dünne Film-Pulverbeschichtung
WO2003062687A3 (fr) Tuyauterie acoustique active
WO2005098083A3 (fr) Application de chalumeau a plasma micro-onde miniature et procede d'utilisation correspondant
JP2003524592A5 (fr)
PT1590065E (pt) Filtros para a separa??o de leuc?citos de sangue total ou de preparados sangu?neos, processo para a prepara??o destes filtros, dispositivo e utiliza??o
WO2005023923A3 (fr) Procedes de traitement de nanocristaux et compositions, dispositifs et systemes comprenant ces nanocristaux
CA2370073A1 (fr) Appareil a pompe de colostomie
FR2825292B1 (fr) Procede d'enrobage d'une substance active dans un complexe interpolymere
MXPA04000201A (es) Metodo y aparato para preparar particulas.
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2002071248A3 (fr) Procedes et dispositifs pour mettre en forme et/ou traiter des donnees
DE69932182D1 (de) Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden.
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
FR2824255B1 (fr) Paillette pour la conservation de petites quantites de substances, notamment de liquides biologiques
WO2005047188A3 (fr) Systemes et procedes pour le traitement de liquides
ATE416035T1 (de) Dosiervorrichtung
SE0202360L (sv) System och förfarande för förbättring av rörelsen och utmatningen av material från kärl
ITMI20031900A1 (it) Dispositivo per la distribuzione e l'aspirazione uniforme di piccole quantita' di fluidi.
FR2829220B1 (fr) Coudes pour circuit de tuyauterie notamment pour le transport pneumatique de poudres ou granules
FR2700809B1 (fr) Dispositif de pompage pour produit coulant, notamment pour liquide.
WO2003092647A3 (fr) Systeme de transport dans des systemes biologiques
IT1303387B1 (it) Procedimento e dispositivo di fabbricazione di prodotti utilizzandomateriali di scarto di vario genere, e prodotto cosi' ottenuto.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16